Raymond James & Associates Hexo Corp. Transaction History

Raymond James & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.2 - $0.61 $999 - $3,049	4,999 Added 37.16%	18,451 $4,000
Q1 2022 May 11, 2022	SELL	$0.48 - $0.74 $341 - $526	-712 Reduced 5.03%	13,452 $8,000
Q4 2021 Feb 08, 2022	SELL	$0.7 - $1.94 $1,073 - $2,974	-1,533 Reduced 9.77%	14,164 $10,000
Q3 2021 Nov 02, 2021	BUY	$1.82 - $5.71 $400 - $1,256	220 Added 1.42%	15,697 $29,000
Q2 2021 Aug 11, 2021	BUY	$5.22 - $7.33 $7,965 - $11,185	1,526 Added 10.94%	15,477 $90,000
Q1 2021 May 14, 2021	BUY	$4.0 - $10.28 $55,804 - $143,416	13,951 New	13,951 $90,000

23.7K

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.